← All indications
Erythroblastosis, Fetal
A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.
Subtype terms (2)
More specific conditions that are subtypes of Erythroblastosis, Fetal in the MeSH hierarchy.
- Hydrops Fetalis
1 drug experimental
- Kernicterus
1 drug approved
Drugs by status
Phase 4 trials (2)
Phase 3 trials (1)
Phase 2 trials (1)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (2)